This summary was created by AI, based on 1 opinions in the last 12 months.
The BMO EqWt US HthCare Hedged CAD ETF (ZUH-T) has received positive reviews from experts, with a low management expense ratio of 0.72% making it an attractive option for investors. Its unique non-market cap weighted approach makes it easy to understand and potentially offers diversification benefits to the investors. Overall, the ETF seems to be well-received and offers a compelling investment opportunity in the healthcare sector.
They use a covered call strategy to enhance the yield. Those who want exposure to healthcare space but want higher yield, it is a good option. If yield is not a concern for you, you're better off with ZUH.
Billy Kawasaki’s Insights - Picks from 5i Research. Healthcare is likely to be a strong performer in the next five years. Subsectors like medical devices, telemedicine and therapeutics should lead. A good ETF for US exposure. Unlock Premium - Try 5i Free
He does not own this one. They have an effective covered call strategy and has no issues with the fund at all. He prefers ZUH, where it is not impeded with calls being written.
Healthcare ETF? He likes ZUH as it includes pharma, hospitals and other medical services. It is hedged to the Canadian dollar.
60 names, equally weighted. Prefers names like JNJ, Bristol Myers, UNH, or Merck. His ETF strategy is VHT in US dollars, with more exposure to larger names. Healthcare will be choppy, but it's cheap. Demographics are in its favour.
BMO EqWt US HthCare Hedged CAD is a Canadian stock, trading under the symbol ZUH-T on the Toronto Stock Exchange (ZUH-CT). It is usually referred to as TSX:ZUH or ZUH-T
In the last year, 1 stock analyst published opinions about ZUH-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for BMO EqWt US HthCare Hedged CAD.
BMO EqWt US HthCare Hedged CAD was recommended as a Top Pick by on . Read the latest stock experts ratings for BMO EqWt US HthCare Hedged CAD.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered BMO EqWt US HthCare Hedged CAD In the last year. It is a trending stock that is worth watching.
On 2025-01-13, BMO EqWt US HthCare Hedged CAD (ZUH-T) stock closed at a price of $67.67.
MER is 0.72%. Easy to understand. Not a market cap weighted ETF